AAMU
SAGE

Amundi Asset Management US’s Sage Therapeutics SAGE Stock Holding History

Amundi Asset Management US’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$15.4M Sell
205,689
-3,713
-2% -$304K 0.01% 739
2020
Q4 		$18.1M Sell
209,402
-13,731
-6% -$1.01M 0.02% 661
2020
Q3 		$13.6M Buy
223,133
+37,343
+20% +$1.89M 0.01% 651
2020
Q2 		$7.72M Sell
185,790
-4,932
-3% -$179K 0.01% 766
2020
Q1 		$5.48M Sell
190,722
-23,594
-11% -$1.37M 0.01% 717
2019
Q4 		$15.5M Buy
214,316
+36,334
+20% +$4.47M 0.02% 643
2019
Q3 		$25M Sell
177,982
-13,475
-7% -$2.25M 0.04% 451
2019
Q2 		$35.1M Buy
191,457
+54,998
+40% +$9.38M 0.03% 414
2019
Q1 		$21.7M Buy
136,459
+39,447
+41% +$5.71M 0.03% 507
2018
Q4 		$9.29K Buy
97,012
+927
+1% +$106K 0.01% 680
2018
Q3 		$13.6M Sell
96,085
-7,822
-8% -$1.21M 0.02% 662
2018
Q2 		$16.3M Sell
103,907
-30
-0% -$4.71K 0.02% 575
2018
Q1 		$16.7M Sell
103,937
-17,071
-14% -$2.9M 0.03% 538
2017
Q4 		$19.9M Sell
121,008
-60,120
-33% -$5.83M 0.03% 460
2017
Q3 		$11.3M Buy
181,128
+22,710
+14% +$1.78M 0.04% 289
2017
Q2 		$12.6M Buy
158,418
+88,585
+127% +$6.4M 0.04% 278
2017
Q1 		$4.96M Buy
+69,833
New +$4.09M 0.02% 408

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amundi Asset Management US's SAGE Position: Q1 2021 in Review

Amundi Asset Management US reduced its Sage Therapeutics (SAGE) stake by 1.8% in Q1 2021, selling an estimated $304K and leaving 205,689 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #739.

Amundi Asset Management US first reported a position in SAGE in Q1 2017 and has held it in 17 quarters since. The position peaked at $35.1M in Q2 2019. 263 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

  • Amundi Asset Management US held 205,689 shares of Sage Therapeutics worth $15.4M as of Q1 2021.
  • Amundi Asset Management US sold 3,713 Sage Therapeutics shares in Q1 2021, an estimated $304K.
  • Sage Therapeutics made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #739 holding.
  • Amundi Asset Management US first reported a position in Sage Therapeutics in Q1 2017 and has held it in 17 quarters since.
  • Amundi Asset Management US's Sage Therapeutics position peaked at $35.1M in Q2 2019.
  • 263 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.